Veraxa Biotech Holding AG (VRXA) Enterprise Value (2024 - 2025)

Veraxa Biotech Holding AG (VRXA) has reported Enterprise Value for 2 consecutive years, with -$1.5 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Enterprise Value rose 75.91% year-over-year to -$1.5 million; the trailing twelve-month figure through Dec 2025 stood at -$1.5 million (up 75.91% YoY), and the FY2025 full-year result was -$1.5 million, up 75.91% from the prior year.
• Enterprise Value advanced to -$1.5 million in Q4 2025 per VRXA's latest filing, from -$6.3 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$1.5 million in Q4 2025 to a low of -$6.3 million in Q4 2024.